Loading...

ELITE PHARMACEUTICALS INC Investor Conferences 8-K Filing

LT P

ELITE PHARMACEUTICALS INC

()

2025 8-K

Product Launch Announcement

Financial Results Report

Conference Call Announcement

Quarterly Financial Report

Conference Call Update

FDA Approval Granted

Conference Call Announcement

Quarterly Results Update

Financial Statements

Clinical Trials

New Product Launches

Product Shipment

Quarterly Results

External Links:

Elite Pharmaceuticals Inc. announced a conference call on November 14, 2025, to discuss its financial results for Q2 FY 2026, which ended on September 30, 2025. For inquiries, contact dianne@elitepharma.com by November 13, 2025.

AI Assistant

ELITE PHARMACEUTICALS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.